1-3 of 3
Charlotte Pawlyn, BA, PhD MBBChir, MRCP, FRCPath
Close
Sort by
Journal Articles

Cyclophosphamide, Pomalidomide and Dexamethasone Significantly Improves Response over Poma/Dex in Relapsed/Refractory Myeloma Patients Previously Treated with Cyclophosphamide Combination Therapy - Initial Results of the Randomised Multicentre Mukseven Trial

James Croft, BSc, MBBS, MRCP, Andrew Hall, Katrina Walker, Amy L Sherborne, PhD, Sidra Ellis, Amy Price, Debbie Sherratt, Sadie Reed, PhD, Charlotte Pawlyn, BA, PhD MBBChir, MRCP, FRCPath, Mamta Garg, Kevin Boyd, Gordon Cook, Sarah R Brown, PhD MSc, BSc, Martin Kaiser, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3274.
https://doi.org/10.1182/blood-2018-99-111835
Published: 2018
Journal Articles

Cyclophosphamide Exerts Significant Immunomodulatory Function in Myeloma Patients Treated with Pomalidomide and Dexamethasone

James Croft, BSc, MBBS, MRCP, Andrew Hall, Katrina Walker, Amy L Sherborne, PhD, Kevin Boyd, Mamta Garg, Charlotte Pawlyn, BA, PhD MBBChir, MRCP, FRCPath, Debbie Sherratt, Sadie Reed, PhD, William E Pierceall, Gordon Cook, Anjan Thakurta, PhD, Sarah R Brown, PhD MSc, BSc, Martin Kaiser, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4482.
https://doi.org/10.1182/blood-2018-99-111823
Published: 2018
Journal Articles

Maximizing Pre-Transplant Response Is Associated with Improved Outcome for Myeloma Patients: Exploratory Analysis of the Myeloma XI Trial

Charlotte Pawlyn, BA, PhD MBBChir, MRCP, FRCPath, Graham H Jackson, David Cairns, Alina Striha, Anna Hockaday, Gwen Jacques, John R Jones, Kevin Boyd, Bhuvan Kishore, Mamta Garg, Catherine Williams, Kamaraj Karunanithi, Jindriska Lindsay, Matthew Jenner, Gordon Cook, Nigel H. Russell, Martin Kaiser, MD, Mark T Drayson, Roger G. Owen, Walter M Gregory, Gareth Morgan, MD, Faith E. Davies, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3280.
https://doi.org/10.1182/blood-2018-99-118868
Published: 2018